Historical record - last NADAC effective date: 4/22/2020
Product Information
RANITIDINE 150 MG TABLET is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $0.0865 per EA under NDC 53746025305. Its NADAC has been published 386 times since Nov 28, 2013.
FDA first approved this application on Oct 13, 2006.
Strength
150 mg/1
Manufacturer
Amneal Pharmaceuticals of New York LLCNDC
53746025305
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
4/22/2020
Active Ingredients
RANITIDINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077824FDA Approved
10/13/2006
On Market Since
12/16/2009
Pharmacological Classes
Price Statistics
The NADAC for RANITIDINE 150 MG TABLET has been published 386 times since Nov 28, 2013, and over the history we have for it it has risen 42.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0865 per EA |
|---|---|
| All-time high | $0.1044 (Mar 11, 2020) |
| All-time low | $0.0431 (Mar 20, 2019) |
| Median price | $0.0566 |
| Average price | $0.0610 |
| Largest weekly change | +63.3% (Feb 19, 2020) |
| Weeks tracked | 386 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+42.8%
Last surveyed Apr 14, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals of New York LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ranitidine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-2 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of RANITIDINE 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RANITIDINE 150 MG TABLET, manufactured by Amneal Pharmaceuticals of New York LLC, is $0.0865 per EA (NDC 53746025305), effective Apr 14, 2021.
How has the price of RANITIDINE 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for RANITIDINE 150 MG TABLET has risen 42.8%. It has been tracked across 386 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for RANITIDINE 150 MG TABLET?
Since Nov 28, 2013, the NADAC for RANITIDINE 150 MG TABLET has ranged from a low of $0.0431 (Mar 20, 2019) to a high of $0.1044 (Mar 11, 2020), with a median of $0.0566 per EA.
Are there cheaper alternatives to RANITIDINE 150 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as RANITIDINE 150 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures RANITIDINE 150 MG TABLET?
RANITIDINE 150 MG TABLET (NDC 53746025305) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.